Table 2

Transplant characteristics of the patients with and without recurrence of LN

Patient	U/P ratio	GFR	Allograft type	Time from Tx to bx, years	LN class native bx	LN class Tx bx	IF/Ta score
1	42	42	LD	6	NA	II	2
2	6	63	LD	9	IV	I	0
3	9	26	DD	9	TMA	I	1
4	6	63	LD	7	IV	I	0
5	30	58	LD	15	IV	I	1
6	8	58	LD	18	IV	II	1
7	387	14	LD	12	IV	II	2
8	19	53	DD	3	IV	II	1
9	223	45	LD	10	IV	II	1
10	15	39	LD	6	IV	I	1
11	300		DD	11	NA	III+V (a)	2
12	15	52	LD	4	IV	I	0
13	10	52	LD	6	IV	I	1
14	25	59	LD	8	V	II	1
15	17	37	LD	12	IV	I	1
16	143	20	DD	3	NA	IV	3
17	63	75	DD	3	IV	II	1
18	20	33	DD	9	IV	V	2
19	12	36	LD	16	IV	I	1
20	10	19	DD	4	NA	V	1
21	60		LD	7	NA	III (a)	1
22	133	18	LD	4	NA	I	1
23	9	54	DD	2	IV		1
24	6	60	DD	2	IV		1
25	12	38	LD	21	NA		1
26	18	37	LD	10	NA		2
27	14	38	DD	11	III		1
28	18	31	DD	6	NA		2
29	26	44	LD	4	IV		2
30	5	48	DD	8	NA		1
31	15	67	LD	16	IV		1
32			LD	12	NA		1
33	6	76	DD	2	III		0
34	9	36	DD	4	III		1
35	7	81	DD	5	IV		0
36	5	52	DD	12	IV		1
37	9	72	DD	4	NA		0
38	10	29	DD	5	IV		2
39	27	32	LD	22	NA		1
40	11	55	LD	27	IV		0
41	7	68	DD	6	NA		1

(a), positive activity index; bx, biopsy; DD, deceased donor; GFR, glomerular filtration rate (ml/min); IF/TA, interstitial fibrosis/tubular athrophy; LD, living donor; LN, lupus nephritis; NA, not available; TMA, thrombotic microangiopathy; tx, transplantation; U/P, urine protein ratio (mg/mmol creatinine).